Bimatoprost 0.03% Versus Brimonidine 0.2% in the Prevention of Intraocular Pressure Spike Following Neodymium:Yttrium-Aluminum-Garnet Laser Posterior Capsulotomy

Artunay, Ozgur; Yuzbasioglu, Erdal; ÜNAL, MUSTAFA; Rasier, Rifat; Sengul, Alper; Bahcecioglu, Halil

doi:10.1089/jop.2009.0146

Bimatoprost 0.03% Versus Brimonidine 0.2% in the Prevention of Intraocular Pressure Spike Following Neodymium:Yttrium-Aluminum-Garnet Laser Posterior Capsulotomy

Atıf İçin Kopyala

Artunay O., Yuzbasioglu E., ÜNAL M., Rasier R., Sengul A., Bahcecioglu H.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, cilt.26, sa.5, ss.513-517, 2010 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Sayı: 5
Basım Tarihi: 2010
Doi Numarası: 10.1089/jop.2009.0146
Dergi Adı: JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.513-517
Akdeniz Üniversitesi Adresli: Evet

Özet

Purpose: The aim of this study was to compare the efficacy of bimatoprost 0.03% with brimonidine 0.2% in preventing intraocular pressure (IOP) elevations after neodymium: yttrium-aluminum-garnet (Nd:YAG) laser posterior capsulotomy.